OpenAlex
PricingAboutJobs
Log inGet started
Work

Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes

HTML

Year: 2025
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc2515117
Authors: Julio Rosenstock, David Cox, Max Denning
Institutions: Medical City Dallas Hospital, Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: orforglipron, GLP-1 receptor agonists, type 2 diabetes, early type 2 diabetes, oral administration, cAMP signaling, beta-arrestin, receptor desensitization, long-term safety, cardiovascular risk
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4417035355
Cites: 12
Cited by: 2
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security